News archive for Brain tumour immunology and therapy group
Bortezomib as chemosensitizer for glioblastoma patients with unmethylated MGMT promoter: Phase IB/II clinical trial and mechanisms of therapeutic efficacy
- September 2023 (2)
- May 2023 (1)
- September 2021 (1)
- May 2021 (1)
- March 2021 (1)
- February 2021 (1)
- October 2020 (1)
- September 2019 (1)
- August 2019 (1)
- November 2018 (1)
- October 2018 (1)
- May 2018 (1)
- April 2018 (1)
- November 2017 (1)
- June 2014 (1)